Cure8 Ventures
Venture capitalSt. Louis
Fund manager profile
Cure8 Ventures is a venture fund manager based in St. Louis. SEC filings show 1 venture fund on record, most recently Cure8 Ventures I, LP filed April 2020.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 1 of 1 portfolio companiesBiotech Γ1FoodTech Γ1New Materials Γ1
HQs:United StatesΓ1
Investments Β· 1 tracked
founders shown can be your intro pathBonumose produces tagatose, a naturally occurring "rare sugar" made from plant starch (corn, wheat, cassava) using proprietary enzymes, offering a sugar substitute with a low glycemic index and reduced calories.
BiotechFoodTechNew MaterialsCharlottesville, US
Edwin O. Rogers(Executive Officer, Director)Daniel Wichelecki(Founder & Inventor (PhD, Biochemistry))inMichael Kime(Director)inRobert Sproull(Director)
BoardEdward J. Williams(Director)Michael Salerno(Director)
Co-investorsiSelect Fund
Frequently asked questions
- Where is Cure8 Ventures located?
- Cure8 Ventures is headquartered in St. Louis, US.